Compare AU
Compare AESG vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares Global Aggregate Bond Esg (Aud Hedged) ETF (AESG) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
AESG | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 1 | 61 |
Median incremental investment | $1,993.50 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,055.10 | $1,892.10 |
Average age group | > 35 | 26 - 35 |
Key Summary
AESG | DRUG | |
|---|---|---|
Strategy | AESG.AX was created on 2022-08-09 by iShares. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide investors with the performance of an index, before fees and expenses (including the cost of hedging). | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | iShares Global Aggt Bd ESG ETF AUD H Dis (99.94 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (99.97 %) Communication Services (0.03 %) | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.19 % | 0.57 % |
Key Summary
AESG | DRUG | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | Bloomberg MSCI Global Aggregate Sustainable and Green Bond SRI Index - Benchmark TR Net | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.19 % | 0.57 % |
Price | $96.55 | $7.95 |
Size | $78.708 million | $185.172 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 0.84 % | 1.90 % |
Market | ASX | ASX |
First listed date | 10/08/2022 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
AESG | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 1 | 61 |
Median incremental investment | $1,993.50 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,055.10 | $1,892.10 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
AESG | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
AESG | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |